Global Atorvastatin Calcium Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 104505
- Pages: 110
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Atorvastatin Calcium market in this environment.
In terms of revenue, this research report indicated that the global Atorvastatin Calcium market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Atorvastatin Calcium industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Pfizer aims at producing XX K Units Atorvastatin Calcium in 2020, with XX % production to take place in global market, DSM Sinochem Pharmaceuticals accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Atorvastatin Calcium Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Atorvastatin Calcium Market
Pfizer
DSM Sinochem Pharmaceuticals
Cadila Pharmaceuticals
Sun Pharmaceutical Industries
Dr. Reddy's
Morepen
Teva Pharmaceutical Industries
Apotex Pharmachem
Zheijang Neo-Dankon Pharmaceutical
Ningbo Menovo Pharmaceuticals Group
Jialin Pharmaceutical
Topfond
Zhejiang Hisun Pharmacutical
Zhejiang Hongyuan Pharmaceutical
Hubei Yitai Pharmaceutical
Jiangsu Hengrui Medicine
...
Major Type of Atorvastatin Calcium Covered in Prudent Markets report:
Chemical Synthesis
Biocatalysis
Application Segments Covered in Prudent Markets Market
Tablet
Capsule
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Atorvastatin Calcium Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Chemical Synthesis -Product Introduction and Major Manufacturers
1.1.2 Biocatalysis -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Atorvastatin Calcium Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Atorvastatin Calcium Market
3.1.1 Top Companies leading Atorvastatin Calcium Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Atorvastatin Calcium Market
3.2.1 Top Companies leading Atorvastatin Calcium Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Atorvastatin Calcium Market
3.3.1 Top Companies leading Atorvastatin Calcium Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Atorvastatin Calcium Market
3.4.1 Top Companies leading Atorvastatin Calcium Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Atorvastatin Calcium Market
3.5.1 Top Companies leading Atorvastatin Calcium Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Atorvastatin Calcium Market
3.6.1 Top Companies leading Atorvastatin Calcium Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Atorvastatin Calcium Market
3.7.1 Top Companies leading Atorvastatin Calcium Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Atorvastatin Calcium Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Atorvastatin Calcium Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Atorvastatin Calcium Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Atorvastatin Calcium Sales and Growth Rate (2021-2027)
5.2 Global Atorvastatin Calcium Sales Value and Growth Rate (2021-2027)
6 Atorvastatin Calcium Competitive Analysis
6.1 Pfizer
6.1.1 Pfizer Company Profiles
6.1.2 Pfizer Product Introduction
6.1.3 Pfizer Atorvastatin Calcium Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 DSM Sinochem Pharmaceuticals
6.2.1 DSM Sinochem Pharmaceuticals Company Profiles
6.2.2 DSM Sinochem Pharmaceuticals Product Introduction
6.2.3 DSM Sinochem Pharmaceuticals Atorvastatin Calcium Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 Cadila Pharmaceuticals
6.3.1 Cadila Pharmaceuticals Company Profiles
6.3.2 Cadila Pharmaceuticals Product Introduction
6.3.3 Cadila Pharmaceuticals Atorvastatin Calcium Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Sun Pharmaceutical Industries
6.4.1 Sun Pharmaceutical Industries Company Profiles
6.4.2 Sun Pharmaceutical Industries Product Introduction
6.4.3 Sun Pharmaceutical Industries Atorvastatin Calcium Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Dr. Reddy's
6.5.1 Dr. Reddy's Company Profiles
6.5.2 Dr. Reddy's Product Introduction
6.5.3 Dr. Reddy's Atorvastatin Calcium Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Morepen
6.6.1 Morepen Company Profiles
6.6.2 Morepen Product Introduction
6.6.3 Morepen Atorvastatin Calcium Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Teva Pharmaceutical Industries
6.7.1 Teva Pharmaceutical Industries Company Profiles
6.7.2 Teva Pharmaceutical Industries Product Introduction
6.7.3 Teva Pharmaceutical Industries Atorvastatin Calcium Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Apotex Pharmachem
6.8.1 Apotex Pharmachem Company Profiles
6.8.2 Apotex Pharmachem Product Introduction
6.8.3 Apotex Pharmachem Atorvastatin Calcium Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Zheijang Neo-Dankon Pharmaceutical
6.9.1 Zheijang Neo-Dankon Pharmaceutical Company Profiles
6.9.2 Zheijang Neo-Dankon Pharmaceutical Product Introduction
6.9.3 Zheijang Neo-Dankon Pharmaceutical Atorvastatin Calcium Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 Ningbo Menovo Pharmaceuticals Group
6.10.1 Ningbo Menovo Pharmaceuticals Group Company Profiles
6.10.2 Ningbo Menovo Pharmaceuticals Group Product Introduction
6.10.3 Ningbo Menovo Pharmaceuticals Group Atorvastatin Calcium Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Jialin Pharmaceutical
6.12 Topfond
6.13 Zhejiang Hisun Pharmacutical
6.14 Zhejiang Hongyuan Pharmaceutical
6.15 Hubei Yitai Pharmaceutical
6.16 Jiangsu Hengrui Medicine
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
